Same Indication

Nivolumab vs Semaglutide

Nivolumab vs Semaglutide: Overview

This comparison examines the pharmacological differences between Nivolumab and Semaglutide.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Semaglutide: GLP-1 receptor agonist with enhanced albumin binding for extended action.

Pharmacokinetics

Half-life: Nivolumab β€” 27 days; Semaglutide β€” 7 days.

Chemical Properties

Type: Nivolumab β€” Antibody; Semaglutide β€” Protein.